Quarterly Report • May 7, 2007
Quarterly Report
Open in ViewerOpens in native device viewer
| Vorwort Geschäftsverlauf Finanzbericht + + |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ++++ | +++++ +++++ |
+++++ | +++++ +++++ |
+++++ +++++ +++++ |
+ | |||||
| ++++ | +++++ +++++ |
+++++ | +++++ +++++ |
+++++ +++++ +++++ |
+ | |||||
| Quarterly Report | +++ | +++++ | +++++ | + + +++++ |
+ | + +++++ |
+ + |
+ | ||
| 1 January – 3 1 March 2007 |
+ | +++ | +++++ | +++++ | +++++ | + +++++ |
+ + + |
+ + |
||
| ++++ | +++++ | +++++ | + | |||||||
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
| in Euro million | Q1/07 | Q1/06 | Change |
|---|---|---|---|
| Sales and orders position | |||
| Order entry | 26.7 | 40.6 | -34.2% |
| Order backlog as of 03/31 | 65.1 | 85.5 | -23.9% |
| Total sales | 39.4 | 39.1 | 0.9% |
| Sales margin | 8.9% | 9.4% | - |
| Gross profit | 16.6 | 17.6 | -5.4% |
| Gross margin | 42.1% | 45.0% | - |
| Costs of sales | 22.8 | 21.5 | 6.1 % |
| EBITDA | 5.3 | 6.6 | -20.0% |
| EBITDA margin | 13.5% | 17.0% | - |
| EBIT | 3.9 | 4.8 | -18.7% |
| EBIT margin | 9.9% | 12.3% | - |
| Earnings after tax | 3.5 | 3.7 | -4.6% |
| Earnings per share | 0.21 | 0.22 | -4.5% |
| Balance sheet | |||
| Shareholders' equity | 102.6 | 87.7 | 17.1% |
| Equity ratio | 66.7% | 55.4% | - |
| Return on equity | 3.4% | 4.2% | - |
| Balance sheet total | 153.9 | 158.1 | -2.7% |
| Net cash | 15.1 | 14.1 | 7.2% |
| Free cash flow | 0.5 | 6.7 | -92.7% |
| Other key figures | |||
| Investments | 1.7 | 1.7 | 2.3% |
| Investment ratio | 4.4% | 4.4% | - |
| Depreciation | 1.4 | 1.8 | -23.3% |
| Employees as of 03/31 | 771 | 689 | 11.9% |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++
02 Foreword by the Management Board
+ ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
+++++++++++++++++++++++++++++++++++++++++++++ +++
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
From left to right: Dr. Stefan Schneidewind (Chief Executive Officer)
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
02
+
Dr. Stefan Reineck (Management Board)
+++++++++++++++++++++++++++++
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Following a very successful 2006, which brought us back into the profit zone after four consecutive deficit years, we have also started well in the 1st quarter of 2007. At EUR 39.4 million, sales even slightly exceeded those of the very strong 1st quarter of 2006 (EUR 39.1 million). More importantly, we have proved that we are sustainably profitable and that the previous year's very good results were not an exception. The operating result (EBIT) turned out somewhat lower at EUR 3.9 million than in the 1st quarter of 2006,when the EBIT was EUR 4.8 million (minus 19 percent).This is particularly due to higher production costs, which reduced gross earnings (gross operating result of sales) from EUR 17.6 million to EUR 16.6 million (minus 5 percent) and contributed to an EBIT margin of 9.9 percent. However, the picture of earnings after taxes (EAT) is very positive; at EUR 3.5 million they are almost as high as in the 1st quarter of 2006 when after-tax earnings were EUR 3.7 million (minus 5 percent). This was due to the lower interest expenditures with simultaneously higher interest earnings and lower taxes on earnings than in the corresponding period.
At EUR 26.7 million, the order entry fell significantly in comparison with the 1st quarter of 2006, as orders up to EUR 40.6 million were entered (minus 34 percent). However, this decrease was anticipated due to the reserved atmosphere in the semiconductor equipment sector and has been taken into account in our internal planning. In particular in Asia, where important customers placed large orders in the previous year, we were aware that a break would occur. Nevertheless, we are still expecting the sectoral trend to begin to do well from the middle of the year. Overall, the above-mentioned figures prove that we are following the right product and sales strategy and have the cost structure under control.
We are also very satisfied with the progress in our C4NP project.The delivery and installation of the high-volume production tool at IBM in East Fishkill, USA, is taking place as planned. IBM has already installed several systems necessary for the C4NP process and has started the lead-free C4NP bumping process. IBM, which is better positioned than ever before as a technology leader in the semiconductor manufacturing industry, remains focused on C4NP as a lead-free backend technology and places its trust in SUSS MicroTec as the leading provider of advanced packaging solutions. We are therefore expecting interest in this technology to continue to grow within the semiconductor industry.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
The example of C4NP demonstrates that we continue to occupy a leading position in our industry in the development of innovative technology. At the same time, we are not betting on a single horse, but are driving forward innovations such as 3D stacking and silicon-on-insulator (SOI) technologies, all of which will give impetus to our Wafer Bonder (Substrate Bonder) business. The aforementioned technologies will be required for example in the production of microchips for the next generation of mobile telecommunications terminals such as Internet-capable cell phones and handhelds – a sector with large growth potential.
The expected increase in sales in the Substrate Bonder segment should balance out decreases in sales within the Lithography segment, enabling us to adhere to our ambitious guidance for 2007.
+ + + + ++++++++++++++++++++++++++++++++++++++
Garching, May 2007
Dr. Stefan Schneidewind Dr. Stefan Reineck Chief Executive Officer Management Board
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
As expected, Lithography, the largest business segment by far, developed weakly in the 1st quarter of 2007 following the boom year of 2006. Sales decreased in comparison with the 1st quarter of 2006 from EUR 25.7 million to EUR 21.6 million (minus 16 percent), the segment result went down from EUR 5.6 million to EUR 4.5 million (minus 19 percent) and order entry halved from EUR 25.3 million to EUR 12.7 million.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
Demand was greatest for our newly developed machines such as the MA200Compact Mask Aligner and the fully automatic Spin Coater, which has by now become standard equipment for microstructuring. This also applies to our Spray Coater, the development of which is based on a SUSSowned patent. The delivery of a MA200Compact to the Japanese group Seiko Epson represents a milestone.The worldwide leader in products and services in the area of photographic printing and digital imaging chose the SUSS Mask Aligner because it allows cost-effective development of new and demanding system solutions in the area of advanced packaging. The MA200Compact has therefore successfully pushed forward into a new area of application of high technical requirements, which had been previously held by the rival, more cost-intensive 1X Steppers technology.
The most important market for the SUSS MicroTec Lithography systems remains the tiny world of microsystems technology.With the DSM200 we have now brought onto the market a new, fully automated measuring device which recognizes incorrectly positioned structures on a wafer as early as during the first steps of the process, contributing to an increase in the yield and therefore to a reduction in costs.The DSM200 is already being employed by several production customers for testing print heads and sensors, primarily in the automotive and consumer goods sector.This machine opens a completely new market segment of outstanding prospects for SUSS MicroTec.
Our strong customer orientation has also paid off: STMicroelectronics, a worldwide leader of integrated circuits based in Tours, France, conferred upon us the Supplier Award.The award is in recognition of the good collaboration with the Lithography division of SUSS MicroTec in the areas of service, sales and technical cooperation.
The second largest segment Test Systems developed very steadily in the 1st quarter of the new year. Sales climbed from EUR 6.5 million to EUR 6.8 million (plus 4 percent). However, EUR 0.3 million less were earned than in the previous year's quarter (EUR 0.6 million or minus 60 percent), resulting from a strategy that deliberately aims to penetrate the 300-millimeter market in Asia. The order entry also developed positively by even rising slightly from EUR 5.7 million to EUR 6.2 million; in Japan the figures were EUR 1.7 million following only EUR 0.2 million in the 1st quarter of 2006.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
Our US-based business proved to be the growth engine it was anticipated to be. At EUR 6.3 million, sales almost doubled (plus 93 percent) in comparison with the 1st quarter of 2006 (EUR 3.3 million). It was particularly pleasing to see that the investments in this area showed a positive result for the first time: plus EUR 0.1 million following a loss of the same amount in the 1st quarter of 2006. The order entry has not yet fulfilled all expectations: at EUR 3.2 million, this was below the volumes of the corresponding period by EUR 1.5 million. However, upon viewing the regional distribution of the order entries, it is possible to see that orders are now coming in larger numbers from the North America region. At EUR 1.6 million, these figures were even above the planned figures, which shows that the investments made in research, development and distribution in the American market are beginning to pay off. In a second step, we now also want to establish this successful expansion strategy in the Asian market.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
06
The Device Bonder segment, based in France, traditionally shows large fluctuations in sales and results. In the 1st quarter of 2006, sales of only EUR 0.3 million were realized. They were EUR 1.5 million in the 1st quarter of the new year. Correspondingly, the loss decreased from EUR 0.3 million to EUR 0.1 million. The order entry dropped in the 1st quarter of 2007 in comparison with the 1st quarter of the previous year from EUR 1.6 million to EUR 1.1 million.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
16 14 12 10 8 4 -2 Order entry Segment sales Segment result Net assets 3.3 -0.7 14.4 3.3 3.3 -0.8 3.5 Q1 2006 Q1 2007 11.2
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
Looking at regional sales distribution, it becomes obvious that Europe was able to make an increase to an above-average degree, from EUR 8.3 million to EUR 14.6 million in the corresponding period. In the American market by contrast, sales fell slightly (from EUR 12.3 million to EUR 10.8 million). There was a mixed picture in Asia with a small plus in China and Japan, and a minus in Taiwan and in the rest of Asia.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
In contrast, America was almost able to reach the high level of the 1st quarter of 2006 (EUR 9.1 million following EUR 9.5 million), while Europe remained below expectations (EUR 8.0 million following EUR 12.5 million) and all markets in Asia received fewer orders. The decrease is particularly significant in Taiwan (EUR 2.0 million following EUR 9.0 million).The order entry on the American market, which remained at a steady high level despite the weak dollar, demonstrated however that we have the right products in our portfolio for new applications.
Q1 2006. ∑: 40.6
In total, the order backlog decreased to EUR 65.1 million as of March 31, 2007, while this had been EUR 85.5 million one year earlier. The backlog in America was at a similarly high level as in the corresponding period (EUR 24.8 million following EUR 26.2 million), while this decreased sharply in Europe (EUR 16.5 million following EUR 25.0 million).The picture was mixed in Asia where decreases in China,Taiwan and the rest of Asia stand in contrast to a rise in Japan.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
| Management Board | Shares | Options |
|---|---|---|
| Dr. Stefan Schneidewind | 13,278 | 80,000 |
| Dr. Stefan Reineck | 600 | 0 |
| Supervisory Board | Shares | Optionen |
| Dr. Winfried Süss | 1,131,000 | 0 |
| closing associated persons as defined by § 15a WpHG (Securities Trade Act) |
147,443 | 0 |
| Gerhard Rauter | 0 | 0 |
| Peter Heinz | 1,338 | 0 |
| Prof. Dr. Anton Heuberger | 0 | 0 |
| Dr. Christoph Schücking | 500 | 0 |
| Dr. e. h. Horst Görtz | 17,216 | 0 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
| TEUR |
|---|
| Sales |
| Cost of sales |
| Gross profit |
| Selling costs |
| Research and development costs |
| Administration costs |
| Other operating income |
| Other operating expenses |
| Analysis of net income from operations (EBIT): |
| EBITDA (Earnings before Interest and Taxes, Depreciation and Amortization) |
| Depreciation and amortization of tangible assets, |
| intangible assets and investments in subsidiaries |
| Net income from operations (EBIT) |
| Interest expenses |
| Interest income |
| Income before taxes |
| Income taxes |
| Net profit or loss |
| Thereof minority interests |
| Thereof equity holders of SUSS MicroTec |
| Earnings per share |
| Basic earnings per share in EUR |
| Diluted earnings per share in EUR |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| + | + | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreword | Sales and Earnings | Financial Report |
| 01/01/ – 03/31/2007 | 01/01/ – 03/31/2006 |
|---|---|
| 39,412 | 39,061 |
| -22,809 | -21,501 |
| 16,603 | 17,560 |
| -5,778 | -5,700 |
| -1,893 | -2,125 |
| -5,072 | -5,042 |
| 453 | 739 |
| -409 | -629 |
| 5,305 | 6,629 |
| -1,401 | -1,826 |
| 3,904 | 4,803 |
| -150 | -380 |
| 142 | 91 |
| 3,896 | 4,514 |
| -401 | -849 |
| 3,495 | 3,665 |
| 46 | 19 |
| 3,449 | 3,646 |
| 0.21 | 0.22 |
| 0.20 | 0.20 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
12
+
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | Foreword + |
+ | + | + | + + |
+ | + | + | + | + | + | + | + | + | Sales and Earnings + |
+ | + + |
+ | + | + | Financial Report + |
+ | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
++++++++++++++++++++++++++++++++++++++++++ +++ +
| TEUR | ||
|---|---|---|
| LIABILITIES & SHAREHOLDERS' EQUITY | 03/31/2007 | 12/31/2006 |
|---|---|---|
| Shareholders' equity | 102,618 | 99,155 |
| Subscribed capital | 17,008 | 17,007 |
| Reserves | 85,875 | 82,339 |
| Accumulated other comprehensive income | -474 | -354 |
| Minority interests | 209 | 163 |
| Non-current liabilities | 10,551 | 11,787 |
| Pension provisions | 2,626 | 2,596 |
| Other provisions | 560 | 586 |
| Financial debt | 2,193 | 2,677 |
| Other liabilities | 140 | 195 |
| Deferred tax liabilities | 5,032 | 5,733 |
| Current liabilities | 40,720 | 46,333 |
| Other provisions | 4,543 | 5,030 |
| Tax liabilities | 1,614 | 1,338 |
| Financial debt | 4,890 | 3,116 |
| Accounts payable | 5,492 | 6,418 |
| Other liabilities | 24,181 | 30,431 |
| Balance sheet total | 153,889 | 157,275 |
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14
+
| TEUR | 01/01/ – 03/31/2007 |
01/01/ – 03/31/2006 |
|---|---|---|
| Net profit or loss | 3,495 | 3,665 |
| Amortization of intangible assets | 881 | 1,227 |
| Depreciation of tangible assets | 520 | 599 |
| Profit or loss on disposal of intangible and tangible assets |
104 | 0 |
| Change of reserves on inventories | -156 | 1,822 |
| Change of reserves for bad debts | -112 | -107 |
| Non-cash stock based compensation | 83 | 76 |
| Non-cash income from the reversal of provisions | -85 | -286 |
| Non-cash interest expenses from increase of convertible debt |
4 | 111 |
| Other non-cash effective income and expenses | 226 | 396 |
| Change in inventories | 420 | -6,924 |
| Change in accounts receivable | 5,326 | 6,537 |
| Change in other assets | -1,227 | -1,452 |
| Change in pension provisions | 30 | -24 |
| Change in accounts payable | -900 | 1,812 |
| Change in other liabilities and other provisions | -6,367 | 655 |
| Change of deferred taxes | -6 | 248 |
| Cash flow from operating activities | 2,236 | 8,355 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + Foreword Sales and Earnings Financial Report + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + |
+ | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + |
| TEUR | 01/01/ – 03/31/2007 |
01/01/ – 03/31/2006 |
|---|---|---|
| Payments in tangible assets | -592 | -969 |
| Payments in intangible assets | -1,157 | -741 |
| Cash flow from investing activities | -1,749 | -1,710 |
| Increase of bank loans | 0 | 0 |
| Repayment of bank loans | -605 | -2,430 |
| Change of current bank liabilities | 1,956 | -1,738 |
| Change in other financial debt | -63 | -79 |
| Proceeds from issuance of common stocks | 5 | 0 |
| Cash flow from financing activities | 1,293 | -4,247 |
| Adjustments to funds caused | ||
| by exchange-rate fluctuations | -21 | 30 |
| Change in cash and cash equivalents | 1,759 | 2,428 |
| Funds at beginning of the year | 20,459 | 26,325 |
| Funds at end of the period | 22,218 | 28,753 |
| Cash flow from operating activities includes: | ||
| Interest paid during the period | 146 | 233 |
| Interest received during period | 142 | 91 |
| Tax paid during the period | 227 | 220 |
| Tax refunds during the period | 276 | 0 |
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
| Number of shares |
Subscribed | Additional paid-in |
||
|---|---|---|---|---|
| TEUR | (in thousands) | capital | capital | |
| As of 1 January 2006 | 16,793 | 16,793 | 90,673 | |
| Issuance of subscription rights | 76 | |||
| Net profit loss or loss | ||||
| Unrealized loss from securities, net of tax |
||||
| Foreign currency adjustment | ||||
| As of 31 March 2006 | 16,793 | 16,793 | 90,749 | |
| As of 1 January 2007 | 17,007 | 17,007 | 91,573 | |
| Issuance of shares: Exercise of stock options |
1 | 1 | 4 | |
| Issuance of subscription rights | 83 | |||
| Net profit loss or loss | ||||
| Foreign currency adjustment | ||||
| As of 31 March 2007 | 17,008 | 17,008 | 91,660 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
16
+ + + + + + + +
| + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + Foreword Sales and Earnings Financial Report + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + |
+ | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + |
| Total | Minority interests |
Accumulated other com prehensive income |
Retained earnings |
Earnings reserve |
|---|---|---|---|---|
| 84,165 | 49 | 683 | -24,466 | 433 |
| 76 | ||||
| 3,665 | 19 | 3,646 | ||
| -9 | -9 | |||
| -243 | -243 | |||
| 87,654 | 68 | 431 | -20,820 | 433 |
| 99,155 | 163 | -354 | -9,667 | 433 |
| 5 | ||||
| 83 | ||||
| 3,495 | 46 | 3,449 | ||
| -120 | -120 | |||
| 102,618 | 209 | -474 | -6,218 | 433 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
| Lithography | Substrate Bonder | |||
|---|---|---|---|---|
| TEUR | Q1/2007 | Q1/2006 | Q1/2007 | Q1/2006 |
| Sales | 21,646 | 25,726 | 6,310 | 3,273 |
| Result per segment | 4,509 | 5,588 | 106 | -75 |
| Significant non-cash items | -233 | -812 | -79 | -32 |
| Segment assets | 57,755 | 67,239 | 17,286 | 12,454 |
| - thereof Goodwill | 13,599 | 13,599 | 0 | 0 |
| Unallocated assets | ||||
| Total assets | ||||
| Segment liabilities | -15,702 | -28,438 | -2,766 | -4,253 |
| Unallocated liabilities | ||||
| Total liabilities | ||||
| Depreciation and amortisation | 705 | 968 | 309 | 275 |
| - thereof scheduled | 705 | 808 | 309 | 275 |
| - thereof impairment loss | 0 | 160 | 0 | 0 |
| Capital expenditure | 244 | 160 | 777 | 204 |
| Average workforce during the year | 314 | 280 | 93 | 79 |
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| Sales | Capital expenditure | |||
|---|---|---|---|---|
| TEUR | Q1/2007 | Q1/2006 | Q1/2007 | Q1/2006 |
| Europe | 14,610 | 8,250 | 672 | 740 |
| North-America | 10,795 | 12,332 | 978 | 924 |
| Japan | 4,776 | 4,627 | 20 | 1 |
| Rest of Asia | 9,225 | 13,584 | 39 | 9 |
| Rest of world | 6 | 268 | 40 | 36 |
| Consolidation effects | 0 | 0 | 0 | 0 |
| Total | 39,412 | 39,061 | 1,749 | 1,710 |
| + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + Foreword Sales and Earnings Financial Report + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + |
+ | + | + | + | + | + | + | + |
|---|---|---|---|---|---|---|---|---|
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + | ||||||||
| + |
| Device Bonder | Test Systems | Other | Total | ||||
|---|---|---|---|---|---|---|---|
| Q1/2007 | Q1/2006 | Q1/2007 | Q1/2006 | Q1/2007 | Q1/2006 | Q1/2007 | Q1/2006 |
| 1,508 | 327 | 6,759 | 6,478 | 3,189 | 3,257 | 39,412 | 39,061 |
| -134 | -252 | 257 | 645 | -601 | -787 | 4,137 | 5,119 |
| 218 | -849 | 177 | 185 | 73 | 3 | 156 | -1,505 |
| 6,701 | 6,057 | 16,173 | 16,876 | 19,796 | 14,945 | 117,711 | 117,571 |
| 0 | 0 | 4,294 | 4,538 | 4,766 | 5,247 | 22,659 | 23,384 |
| 36,178 | 40,547 | ||||||
| 153,889 | 158,118 | ||||||
| -3,139 | -2,648 | -4,518 | -6,184 | -5,273 | -3,739 | -31,398 | -45,262 |
| -19,873 | -25,202 | ||||||
| -51,271 | -70,464 | ||||||
| 41 | 48 | 69 | 77 | 277 | 458 | 1,401 | 1,826 |
| 41 | 48 | 69 | 77 | 277 | 458 | 1,401 | 1,666 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 160 |
| 17 | 13 | 60 | 37 | 651 | 1,296 | 1,749 | 1,710 |
| 47 | 38 | 135 | 127 | 177 | 158 | 766 | 682 |
| Q1/2007 | Q1/2006 |
|---|---|
| 76,713 | 76,479 |
| 37,658 | 38,593 |
| 3,954 | 3,644 |
| 568 | 639 |
| 2,443 | 3,532 |
| -3,625 | -5,316 |
| 117,711 | 117,571 |
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
The consolidated financial statements of SUSS MicroTec AG as of December 31, 2006 were prepared in accordance with International Financial Reporting Standards (IFRSs) issued by the International Accounting Standards Board (IASB) and valid as of the balance sheet date. The interim Group financial statements as of March 31, 2007, which have been prepared in accordance with International Accounting Standard (IAS) 34 "Interim Financial Reporting", have been drawn up using the same accounting methods as in the 2006 Group financial statements.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +
+ + + + + + +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
All interpretations of the International Financial Reporting Interpretations Committee (IFRIC), which are mandatory as of March 31, 2007 have also been applied.
For additional information on the individual accounting methods applied, please refer to the consolidated financial statements of SUSS MicroTec AG as of December 31, 2006.
The interim financial statements were neither audited, nor did they undergo an auditing review.
All amounts are indicated in thousands of euros (EUR '000) unless otherwise noted.
The financial statements of SUSS MicroTec AG and all of the major companies for which there is a group control option according to the control principle, irrespective of the level of participating interest, are included in the consolidated financial statements. With respect to the consolidated financial statements as of December 31, 2006, there were no changes within the consolidated group.
There were no circumstances during the interim reporting period which had any impact on the assets, liabilities, shareholders' equity, period results or cash flow and which were unusual due to their type, extent or frequency.
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
If estimates were made within the scope of the interim reporting, they shall remain essentially unchanged in methodology within the fiscal year and in the fiscal year comparison.
In contrast to the method of approach at year-end, the income tax expense in each interim reporting period is recorded on the basis of the best estimate of the weighted average annual income tax rate expected for the entire fiscal year.
As a result of valuation allowances made to capitalized loss carry-forwards in the past, SUSS MicroTec AG is presently assuming an annual income tax rate that will be considerably lower than the expected income tax rate of 37%.
Furthermore, there were no changes subject to reporting requirements that have a significant impact on the current interim reporting period.
No issues, buybacks or repayments were effected during the reporting period, either for debenture bonds or for other equity securities.
+ + + + ++++++++++++++++++++++++++++++++++++++
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
No dividends were paid out or proposed for disbursement during the reporting period.
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
There were no significant events subject to reporting requirements after the close of the interim reporting period.
There are no contingent claims. There were no significant changes in contingent liabilities with respect to the reporting time frame of December 31, 2006.
The undiluted earnings per share are determined by dividing the net income for the period accruing to the shares (after minority interests) by the average number of shares.
To determine the diluted earnings per share, the profit for the period to be attributed to the shareholders (after minority interests), as well as the weighted average of the shares in circulation, must be adjusted for the effects of all potentially diluting shares.
22
| May, 03 | Quarterly Report 2007 |
|---|---|
| May, 04 | DVFA-Analysts' Conference, Frankfurt am Main/Germany |
| May, 08-10 | SEMICON Singapore |
| June, 03-08 | MTT-S Symposium, Honolulu/Hawaii |
| June, 04-06 | SEMICON CIS, Moscow/Russia |
| June,10-14 | Transducers 2007, Lyon/France |
| June,13-16 | OPTO Taiwan, Taipei |
| June, 25-27 | Micromachine, Tokyo/Japan |
| July, 06 | General Assembly |
| July,17-19 | SEMICON West, San Fransisco/CA |
| August, 07 | Semiannual Report 2007 |
| September,12-14 | SEMICON Taiwan, Taipei |
| October, 08-12 | European Microwave Week, Munich/Germany |
| October, 09-11 | SEMICON Europa, Stuttgart/Germany |
| November, 06 | Ninemonth Report 2007 |
| December, 05-07 | SEMICON Japan, Chiba |
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
Foreword + Sales and Earnings + Financial Report
Forward-looking statements: The reports contain forward-looking statements. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements are based on current plans, estimates and projections, and you should not place too much reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update any of them in light of new information or future events. Forward-looking statements involve inherent risks and uncertainties. We caution you that a number of important factors could cause actual results or outcomes to differ materially from those expressed in any forwardlooking statement.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ + + +++ ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
| Published by: | SUSS MicroTec AG |
|---|---|
| Edited by: | Investor Relations, Group Accounting & Financial Reporting |
| Concept and design: | IR-One AG & Co., Hamburg |
| Printer: | Hartung Druck + Medien GmbH, Hamburg |
| Translation: | EnglishBusiness GbR, Hamburg |
+ +
+ + + + ++++++++++++++++++++++++++++++++++++++ +
+ +++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ + ++++++++++++++++++++++++++++++++++++++++++ +++ + ++++++++++++++++++++++++++++++++++++++++++ +++ +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
Foreword + Sales and Earnings + Financial Report
SUSS MicroTec AG Schleißheimer Strasse 90 85748 Garching, Germany Fon: +49 (0)89-32007-0 E-mail: [email protected]
Investor Relations Fon: +49 (0)89-32007-454 E-mail: [email protected]
| + + + + + |
+++++ +++++ +++++ +++++ +++++ +++++ |
+++++ +++++ +++++ +++++ +++++ +++++ |
+++++ | +++++ +++++ +++++ +++++ +++++ |
+++++ +++++ +++++ +++++ +++++ +++++ |
+++++ | +++++ +++++ +++++ +++++ +++++ |
+++++ +++++ +++++ +++++ +++++ +++++ |
+++++ | +++++ +++++ +++++ +++++ +++++ |
+++++ | +++++ +++++ +++++ +++++ +++++ |
+++++ +++++ +++++ +++++ +++++ +++++ |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.